<code id='93F8AD5CA6'></code><style id='93F8AD5CA6'></style>
    • <acronym id='93F8AD5CA6'></acronym>
      <center id='93F8AD5CA6'><center id='93F8AD5CA6'><tfoot id='93F8AD5CA6'></tfoot></center><abbr id='93F8AD5CA6'><dir id='93F8AD5CA6'><tfoot id='93F8AD5CA6'></tfoot><noframes id='93F8AD5CA6'>

    • <optgroup id='93F8AD5CA6'><strike id='93F8AD5CA6'><sup id='93F8AD5CA6'></sup></strike><code id='93F8AD5CA6'></code></optgroup>
        1. <b id='93F8AD5CA6'><label id='93F8AD5CA6'><select id='93F8AD5CA6'><dt id='93F8AD5CA6'><span id='93F8AD5CA6'></span></dt></select></label></b><u id='93F8AD5CA6'></u>
          <i id='93F8AD5CA6'><strike id='93F8AD5CA6'><tt id='93F8AD5CA6'><pre id='93F8AD5CA6'></pre></tt></strike></i>

          leisure time

          leisure time

          author:knowledge    Page View:64192
          First Opinion Podcast featured image

          When Prozac first entered the psychiatry scene in in the late ’80s, the profession was still Freud’s territory. Many considered taking medication to treat depression a failure. But that was all about to change, as early stewards like psychiatrist Peter Kramer refused to shy away from the new drug’s potential. These days, he says that people take for granted all of the progress that’s been made with antidepressant treatment in the past three decades.

          “If you were going to be depressed any time in history and were interested in having an effective treatment, you would want to be alive now. But we’ve lost our wonderment about that,” said Kramer, the author of the groundbreaking 1993 book “Listening to Prozac.”

          advertisement

          This week, Kramer joins me to discuss how the country’s relationship with antidepressants has changed since the publication of his book three decades ago. The conversation is based on his First Opinion, “What antidepressants are saying 30 years after the publication of ‘Listening to Prozac.’”

          Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

          focus

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          Harvard's Jason Buenrostro wins MacArthur grant for genetics work

          JasonBuenrostroinhisHarvardlab.CourtesyJohnD.andCatherineT.MacArthurFoundationTheyoungestofthisyear’